GPR177, also known as Wntless (Wls) or Evenness Interrupted (Evi), is a multi-pass transmembrane protein that plays a crucial role in the Wnt signaling pathway, a fundamental pathway involved in embryonic development, cell proliferation, migration, and differentiation. The primary function of GPR177 is to mediate the secretion and transport of Wnt proteins from producing cells to receiving cells. Wnt proteins are a family of highly conserved secreted lipid-modified signaling molecules that regulate a wide range of developmental processes and maintain the homeostasis of tissues in adult organisms. GPR177 is essential for the proper localization and secretion of all Wnt proteins, acting as a key regulator of Wnt protein sorting and secretion in the Wnt-producing cells. By facilitating the movement of Wnt proteins to the plasma membrane and their release into the extracellular space, GPR177 ensures that Wnt signaling can occur, highlighting its indispensable role in the Wnt signaling cascade.
The activation of GPR177 and its role in Wnt protein trafficking involves a complex interplay of cellular mechanisms. Upon Wnt protein binding, GPR177 escorts Wnt from the Golgi apparatus to the plasma membrane, where Wnt proteins are then released to initiate signaling in neighboring cells. This process is tightly regulated by various post-translational modifications of GPR177, including ubiquitination and phosphorylation, which may influence its trafficking and stability. Additionally, the interaction of GPR177 with other proteins involved in vesicular transport is critical for its function in Wnt sorting and secretion. The precise mechanisms controlling GPR177 activation and its interaction with Wnt proteins are subject to ongoing research, aiming to unravel the detailed processes by which GPR177 facilitates Wnt signaling. Understanding the activation and function of GPR177 provides significant insights into the molecular mechanisms governing the Wnt pathway and its implications in developmental biology and disease pathogenesis, emphasizing the importance of GPR177 in cellular communication and signaling networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
LiCl inhibits GSK-3β, thus activating the Wnt signaling pathway, which may increase the activity of GPR177. | ||||||
SKL2001 | 909089-13-0 | sc-507410 | 10 mg | $123.00 | ||
An activator of the Wnt/β-catenin signaling pathway. Its activation of the pathway can indirectly influence GPR177 activity. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
A potent and selective GSK-3β inhibitor, leading to activation of Wnt/β-catenin signaling, potentially influencing GPR177. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Another GSK-3β inhibitor that activates Wnt signaling and thus can indirectly affect GPR177. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
Acts as an antagonist of the PARP domain of tankyrase 1 and 2, leading to stabilization of axin2 and antagonism of Wnt signaling. Its modulation of Wnt signaling can indirectly affect GPR177. | ||||||
IQ-1 | 331001-62-8 | sc-202665 | 10 mg | $180.00 | 2 | |
It prevents the interaction between p300 and β-catenin, thus modulating Wnt signaling and potentially GPR177. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A known HDAC inhibitor, which can enhance Wnt signaling, leading to potential changes in GPR177 activity. | ||||||